Journal of clinical pharmacology

Keyphrases

Publications

volume 64, number 7, 2024

Islam R Younis, Cara Nelson, Elijah J Weber, Ann R Qin, Timothy R Watkins, Ahmed A Othman
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment. Journal of clinical pharmacology 64 (7) (2024)
Marion Anliker-Ort, Frédérique Rodieux, Victoria C Ziesenitz, Andrew Atkinson, Julia A Bielicki, Thomas O Erb, Nicolas Gürtler, Stefan Holland-Cunz, Urs Duthaler, Deborah Rudin, Manuel Haschke, John van den Anker, Marc Pfister, Verena Gotta
Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva - A Case Study. Journal of clinical pharmacology 64 (7) (2024)
Nikita Gupta, Mitali Paryani, Snehal Patel, Aditi Bariya, Anshu Srivastava, Yashwant Pathak, Shital B Butani
Therapeutic Strategies for Idiopathic Pulmonary Fibrosis - Thriving Present and Promising Tomorrow. Journal of clinical pharmacology 64 (7) (2024)
Huixia Zhang, Jie Liu, Vishnu Sharma, Luning Zhuang, Pamela Horn, Ramana Uppoor, Mehul Mehta, Hao Zhu
Pediatric Extrapolation Approach for U.S. Food and Drug Administration Approval of Brexpiprazole in Patients Aged 13 to 17 Years with Schizophrenia. Journal of clinical pharmacology 64 (7) (2024)
Katherine Olney, Joel I Howard, David S Burgess
Daptomycin Dose Optimization in Pediatric Staphylococcus aureus Bacteremia: A Pharmacokinetic/Pharmacodynamic Investigation. Journal of clinical pharmacology 64 (7) (2024)
Aravind Mittur, Ryan Madanick, Melanie Langlois, Brooks Boyd
Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and Norfenfluramine. Journal of clinical pharmacology 64 (7) (2024)
Mark Ellison, Emily Hutton, Lynn Webster, Phil Skolnick
Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. Journal of clinical pharmacology 64 (7) (2024)
Aravind Mittur, Ryan Madanick, Melanie Langlois, Brooks Boyd
Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and Norfenfluramine. Journal of clinical pharmacology 64 (7) (2024)
John N van den Anker
A big thank you and a warm welcome. Journal of clinical pharmacology 64 (7) (2024)
Islam R Younis, Cara Nelson, Elijah J Weber, Ann R Qin, Timothy R Watkins, Ahmed A Othman
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment. Journal of clinical pharmacology 64 (7) (2024)
Katherine Olney, Joel I Howard, David S Burgess
Daptomycin Dose Optimization in Pediatric Staphylococcus aureus Bacteremia: A Pharmacokinetic/Pharmacodynamic Investigation. Journal of clinical pharmacology 64 (7) (2024)
Huixia Zhang, Jie Liu, Vishnu Sharma, Luning Zhuang, Pamela Horn, Ramana Uppoor, Mehul Mehta, Hao Zhu
Pediatric Extrapolation Approach for U.S. Food and Drug Administration Approval of Brexpiprazole in Patients Aged 13 to 17 Years with Schizophrenia. Journal of clinical pharmacology 64 (7) (2024)

volume 64, number 8, 2024

Vijay Vashi, Janice Laramy, Marc Kamin, Louis Ferrari, Alan Hand
Relative Bioavailability of Cenobamate Administered as a Crushed Tablet, Either Orally or via Nasogastric Tube, versus an Intact Whole Tablet. Journal of clinical pharmacology 64 (8) (2024)
Sean McCann, Victória Etges Helfer, Stephen J Balevic, Chi D Hornik, Stuart L Goldstein, Julie Autmizguine, Marisa Meyer, Amira Al-Uzri, Sarah G Anderson, Elizabeth H Payne, Sitora Turdalieva, Daniel Gonzalez, null null
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. Journal of clinical pharmacology 64 (8) (2024)
Xuanzhen Yuan, Guohua An
Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target-Mediated Drug Disposition Model. Journal of clinical pharmacology 64 (8) (2024)
Tao Long, Sindura Gollamudi, Sudhakar M Pai, null null
ACCP Position Statement on Unregulated Psychotropic Products. Journal of clinical pharmacology 64 (8) (2024)
Jesse C Nussbaum, Azher Hussain, Peter Butera, Anthony P Ford, Michael M Kitt, Edward A O'Neill, Steven Smith, Gabriel Vargas, Terry O'Reilly, Chris Wynne, S Aubrey Stoch, Marian Iwamoto
Single- and Multiple-Dose Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist, in Healthy Adults. Journal of clinical pharmacology 64 (8) (2024)
Yiming Cheng, Xiaomin Wang, Atalanta Ghosh, Jie Pu, Leonidas N Carayannopoulos, Yan Li
Assessment of CYP-Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients with Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome. Journal of clinical pharmacology 64 (8) (2024)
Neil Parrott
Food Effect in Pediatric Populations: Current Practice, Challenges, and Future Potential for Use of Physiologically Based Biopharmaceutics Modeling. Journal of clinical pharmacology 64 (8) (2024)
Likun Ding, Lin Yang, Danjun Ren, Xiaohua Gao, Juanli Zhang, Meiyou Liu, Li Sun, Qingbo Diao, Sheng Feng, Aidong Wen, Jingwen Wang
Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Proline Henagliflozin in Chinese Subjects with Varying Degrees of Liver Dysfunction. Journal of clinical pharmacology 64 (8) (2024)
Natasha Novikov, Akshay Buch, Hua Yang, Michelle Andruk, Guowen Liu, Min Wu, Haley Howell, Brian MacDonald, Will Savage
First-in-Human Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of DISC-0974, an Anti-Hemojuvelin Antibody, in Healthy Participants. Journal of clinical pharmacology 64 (8) (2024)
Yanan Zheng, Lubna Abuqayyas, Angelica Quartino, Ye Guan, Yuying Gao, Lu Liu, Åsa Hellqvist, Gene Colice, Alexander MacDonald
Population Pharmacokinetic Modeling and Exposure-Efficacy and Body Weight-Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma. Journal of clinical pharmacology 64 (8) (2024)
Joy E Obayemi, Lauren Callans, Nikhil Nair, Hui Gao, Divya Gandla, Bao-Li Loza, Sarah Gao, Maedeh Mohebnasab, Jennifer Trofe-Clark, Pamala Jacobson, Brendan Keating
Assessing the Utility of a Genotype-Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study. Journal of clinical pharmacology 64 (8) (2024)
Shuaibing Liu, Xia Yao, Jun Tao, Shiyu Zhao, Suke Sun, Suyun Wang, Xin Tian
Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects. Journal of clinical pharmacology 64 (8) (2024)
Sean McCann, Victória Etges Helfer, Stephen J Balevic, Chi D Hornik, Stuart L Goldstein, Julie Autmizguine, Marisa Meyer, Amira Al-Uzri, Sarah G Anderson, Elizabeth H Payne, Sitora Turdalieva, Daniel Gonzalez, null null
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. Journal of clinical pharmacology 64 (8) (2024)
Sean McCann, Victória Etges Helfer, Stephen J Balevic, Chi D Hornik, Stuart L Goldstein, Julie Autmizguine, Marisa Meyer, Amira Al-Uzri, Sarah G Anderson, Elizabeth H Payne, Sitora Turdalieva, Daniel Gonzalez, null null
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. Journal of clinical pharmacology 64 (8) (2024)
Wei Zhang, Li-Xian Chang, Bei-Bei Zhao, Yi Zheng, Dan-Dan Shan, Bo-Hao Tang, Fan Yang, Yue Zhou, Guo-Xiang Hao, Ya-Hui Zhang, John van den Anker, Xiao-Fan Zhu, Li Zhang, Wei Zhao
Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia. Journal of clinical pharmacology 64 (8) (2024)
Chao Li, Richard A Preston, Emily Dumas, Andrew Beelen, Thomas C Marbury
Effect of Hepatic Impairment on Trilaciclib Pharmacokinetics. Journal of clinical pharmacology 64 (8) (2024)
Chuleephorn Pitayakittiwong, Pakawadee Sermsappasuk, Atibordee Meesing, Siriluk Jaisue
Association of Vancomycin AUC/MIC and Trough Concentration With Early Clinical Response in Enterococcus or Coagulase-Negative Staphylococcus Infection: A Prospective Study. Journal of clinical pharmacology 64 (8) (2024)

volume 64, number 9, 2024

Merel van Nuland
ChatGPT and Factual Knowledge Questions Regarding Clinical Pharmacy: Response to Letter to the Editor. Journal of clinical pharmacology 64 (9) (2024)
Allison Dunn, Marc Ditmarsch, John J P Kastelein, Douglas Kling, Annie Neild, Michael H Davidson, Jogarao V S Gobburu
Guiding Dyslipidemia Treatment: A Population Pharmacokinetic-Pharmacodynamic Framework for Obicetrapib. Journal of clinical pharmacology 64 (9) (2024)
Gary D Novack, Alan L Robin
Ocular Pharmacology. Journal of clinical pharmacology 64 (9) (2024)
Anita Moein, Jin Y Jin, Matthew R Wright, Harvey Wong
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor). Journal of clinical pharmacology 64 (9) (2024)
Jian-Mei Pan, Yu Guo, Fang-Fang Jiang, Ran Xu, Xin Zhang, Wen-Ke Cai, Sun-Jun Yin, Ping Wang, Yan-Hua Huang, Xue-Sha Zhang, Yi-Hua Li, Liao Cai, Gong-Hao He
Effect of Histamine H2 Receptor Antagonists on All-Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort Study. Journal of clinical pharmacology 64 (9) (2024)
Jian-Mei Pan, Yu Guo, Fang-Fang Jiang, Ran Xu, Xin Zhang, Wen-Ke Cai, Sun-Jun Yin, Ping Wang, Yan-Hua Huang, Xue-Sha Zhang, Yi-Hua Li, Liao Cai, Gong-Hao He
Effect of Histamine H2 Receptor Antagonists on All-Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort Study. Journal of clinical pharmacology 64 (9) (2024)
André Dallmann, Donato Teutonico, Stephan Schaller, Rolf Burghaus, Sebastian Frechen
In-Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community. Journal of clinical pharmacology 64 (9) (2024)
Xiaonan Li, Daniele Sabbatini, Elena Pegoraro, Luca Bello, Paula Clemens, Michela Guglieri, John van den Anker, Jesse Damsker, John McCall, Utkarsh J Dang, Eric P Hoffman, William J Jusko
Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy. Journal of clinical pharmacology 64 (9) (2024)
Xiaonan Li, Daniele Sabbatini, Elena Pegoraro, Luca Bello, Paula Clemens, Michela Guglieri, John van den Anker, Jesse Damsker, John McCall, Utkarsh J Dang, Eric P Hoffman, William J Jusko
Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy. Journal of clinical pharmacology 64 (9) (2024)
Xiaonan Li, Daniele Sabbatini, Elena Pegoraro, Luca Bello, Paula Clemens, Michela Guglieri, John van den Anker, Jesse Damsker, John McCall, Utkarsh J Dang, Eric P Hoffman, William J Jusko
Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy. Journal of clinical pharmacology 64 (9) (2024)
Marc Codaccioni, Rosalind L Southall, Jean Dinh, Trevor N Johnson
Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model. Journal of clinical pharmacology 64 (9) (2024)
Massimo Magliocca, Benjamin Berger, Vincent Lemoine, Priska Kaufmann, Jasper Dingemanse
Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A. Journal of clinical pharmacology 64 (9) (2024)
Merel van Nuland, Abdullah Erdogan, Cenkay Aςar, Ramon Contrucci, Sven Hilbrants, Lamyae Maanach, Toine Egberts, Paul D van der Linden
Performance of ChatGPT on Factual Knowledge Questions Regarding Clinical Pharmacy. Journal of clinical pharmacology 64 (9) (2024)
Scott R Penzak, Marilyn Bulloch
Backpedaling on Baclofen: Highlighting Concerns Surrounding Baclofen Use in Phenibut Withdrawal: Letter to the Editor Response. Journal of clinical pharmacology 64 (9) (2024)
Xiaonan Li, Daniele Sabbatini, Elena Pegoraro, Luca Bello, Paula Clemens, Michela Guglieri, John van den Anker, Jesse Damsker, John McCall, Utkarsh J Dang, Eric P Hoffman, William J Jusko
Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy. Journal of clinical pharmacology 64 (9) (2024)
Anthony Lau, Hans Haag, Anil Maharaj
A Simulation-Based Assessment of Levetiracetam Concentrations Following Fixed and Weight-Based Loading Doses: A Meta-Regression and Pharmacokinetic Modeling Analysis. Journal of clinical pharmacology 64 (9) (2024)
Anita Moein, Jin Y Jin, Matthew R Wright, Harvey Wong
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor). Journal of clinical pharmacology 64 (9) (2024)
Dominic Stefan Bräm, Gilbert Koch, Karel Allegaert, John van den Anker, Marc Pfister
Applying Neural ODEs to Derive a Mechanism-Based Model for Characterizing Maturation-Related Serum Creatinine Dynamics in Preterm Newborns. Journal of clinical pharmacology 64 (9) (2024)
Koen P van Rhee, Roger J M Brüggemann, Jason A Roberts, Fredrik Sjövall, Reinier M van Hest, Paul W G Elbers, Alan Abdulla, Paul D van der Linden, Catherijne A J Knibbe
Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity. Journal of clinical pharmacology 64 (9) (2024)
Hineptch Daungsupawong, Viroj Wiwanitkit
ChatGPT and Factual Knowledge Questions Regarding Clinical Pharmacy: Correspondence. Journal of clinical pharmacology 64 (9) (2024)
Ryan Feldman
Back Pedaling on Baclofen: Highlighting Concerns Surrounding Baclofen use in Phenibut Withdrawal. Journal of clinical pharmacology 64 (9) (2024)